Bangladesh Core FHIR Implementation Guide
0.2.3 - Published by DGHS, MoHFW

Bangladesh Core FHIR Implementation Guide - Published by Ministry of Health and Family Welfare. See the Directory of published versions

## : Bangladesh Medication Dose Form CodeSystem - XML Representation

Page standards status: Informative | Maturity Level: 1

Raw xml | Download

    <CodeSystem xmlns="http://hl7.org/fhir">
      <id value="bd-dose-form"/>
      <text>
        <status value="generated"/>
        <div xmlns="http://www.w3.org/1999/xhtml"><div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: CodeSystem bd-dose-form</b></p><a name="bd-dose-form"> </a><a name="hcbd-dose-form"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">TAB<a name="bd-dose-form-TAB"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style="white-space:nowrap">DTAB<a name="bd-dose-form-DTAB"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style="white-space:nowrap">CAP<a name="bd-dose-form-CAP"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style="white-space:nowrap">SYP<a name="bd-dose-form-SYP"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style="white-space:nowrap">SUSP<a name="bd-dose-form-SUSP"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style="white-space:nowrap">PFS<a name="bd-dose-form-PFS"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style="white-space:nowrap">INJ<a name="bd-dose-form-INJ"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style="white-space:nowrap">SOL<a name="bd-dose-form-SOL"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style="white-space:nowrap">CRM<a name="bd-dose-form-CRM"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style="white-space:nowrap">LOT<a name="bd-dose-form-LOT"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div><div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: CodeSystem bd-dose-form</b></p><a name="de-bd-dose-form"> </a><a name="de-hcbd-dose-form"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">TAB<a name="de-bd-dose-form-TAB"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style="white-space:nowrap">DTAB<a name="de-bd-dose-form-DTAB"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style="white-space:nowrap">CAP<a name="de-bd-dose-form-CAP"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style="white-space:nowrap">SYP<a name="de-bd-dose-form-SYP"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style="white-space:nowrap">SUSP<a name="de-bd-dose-form-SUSP"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style="white-space:nowrap">PFS<a name="de-bd-dose-form-PFS"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style="white-space:nowrap">INJ<a name="de-bd-dose-form-INJ"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style="white-space:nowrap">SOL<a name="de-bd-dose-form-SOL"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style="white-space:nowrap">CRM<a name="de-bd-dose-form-CRM"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style="white-space:nowrap">LOT<a name="de-bd-dose-form-LOT"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div><div xml:lang="fr" lang="fr"><hr/><p><b>French</b></p><hr/><p class="res-header-id"><b>Narratif généré : CodeSystem bd-dose-form</b></p><a name="fr-bd-dose-form"> </a><a name="fr-hcbd-dose-form"> </a><p>This  code system <code>https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Affichage</b></td><td><b>Définition</b></td></tr><tr><td style="white-space:nowrap">TAB<a name="fr-bd-dose-form-TAB"> </a></td><td>Tablet</td><td>Solid oral dosage form, usually uncoated or coated, intended for swallowing.</td></tr><tr><td style="white-space:nowrap">DTAB<a name="fr-bd-dose-form-DTAB"> </a></td><td>Dispersible Tablet</td><td>Tablet designed to be dissolved/dispersed in water before administration.</td></tr><tr><td style="white-space:nowrap">CAP<a name="fr-bd-dose-form-CAP"> </a></td><td>Capsule</td><td>Solid dosage form with active ingredients enclosed in a gelatin shell.</td></tr><tr><td style="white-space:nowrap">SYP<a name="fr-bd-dose-form-SYP"> </a></td><td>Syrup</td><td>Liquid oral dosage form containing active substance(s) in solution.</td></tr><tr><td style="white-space:nowrap">SUSP<a name="fr-bd-dose-form-SUSP"> </a></td><td>Suspension</td><td>Liquid oral dosage form with insoluble particles dispersed in a liquid.</td></tr><tr><td style="white-space:nowrap">PFS<a name="fr-bd-dose-form-PFS"> </a></td><td>Powder for Suspension</td><td>Powder that requires reconstitution into a liquid suspension before use.</td></tr><tr><td style="white-space:nowrap">INJ<a name="fr-bd-dose-form-INJ"> </a></td><td>Injection</td><td>Sterile solution or suspension intended for parenteral administration.</td></tr><tr><td style="white-space:nowrap">SOL<a name="fr-bd-dose-form-SOL"> </a></td><td>Solution</td><td>Liquid dosage form where drug is fully dissolved in a solvent.</td></tr><tr><td style="white-space:nowrap">CRM<a name="fr-bd-dose-form-CRM"> </a></td><td>Cream</td><td>Semi-solid topical dosage form containing the drug in an emulsion base.</td></tr><tr><td style="white-space:nowrap">LOT<a name="fr-bd-dose-form-LOT"> </a></td><td>Lotion</td><td>Low-viscosity liquid topical dosage form for external application.</td></tr></table></div></div>
      </text>
      <extension
                 url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
        <valueInteger value="1">
          <extension
                     url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
            <valueCanonical
                            value="https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core"/>
          </extension>
        </valueInteger>
      </extension>
      <extension
                 url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
        <valueCode value="informative">
          <extension
                     url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
            <valueCanonical
                            value="https://fhir.dghs.gov.bd/core/ImplementationGuide/bd.fhir.core"/>
          </extension>
        </valueCode>
      </extension>
      <url value="https://fhir.dghs.gov.bd/core/CodeSystem/bd-dose-form"/>
      <version value="0.2.3"/>
      <name value="BDMedicationDoseForm"/>
      <title value="Bangladesh Medication Dose Form CodeSystem"/>
      <status value="draft"/>
      <date value="2026-03-06T18:02:49+00:00"/>
      <publisher
                 value="Directorate General of Health Services (DGHS), Bangladesh"/>
      <contact>
        <telecom>
          <system value="url"/>
          <value value="http://dghs.gov.bd"/>
        </telecom>
      </contact>
      <description
                   value="Medication dose form codes according to CCDS guideline"/>
      <jurisdiction>
        <coding>
          <system value="urn:iso:std:iso:3166"/>
          <code value="050"/>
        </coding>
      </jurisdiction>
      <content value="complete"/>
      <count value="10"/>
      <concept>
        <code value="TAB"/>
        <display value="Tablet"/>
        <definition
                    value="Solid oral dosage form, usually uncoated or coated, intended for swallowing."/>
      </concept>
      <concept>
        <code value="DTAB"/>
        <display value="Dispersible Tablet"/>
        <definition
                    value="Tablet designed to be dissolved/dispersed in water before administration."/>
      </concept>
      <concept>
        <code value="CAP"/>
        <display value="Capsule"/>
        <definition
                    value="Solid dosage form with active ingredients enclosed in a gelatin shell."/>
      </concept>
      <concept>
        <code value="SYP"/>
        <display value="Syrup"/>
        <definition
                    value="Liquid oral dosage form containing active substance(s) in solution."/>
      </concept>
      <concept>
        <code value="SUSP"/>
        <display value="Suspension"/>
        <definition
                    value="Liquid oral dosage form with insoluble particles dispersed in a liquid."/>
      </concept>
      <concept>
        <code value="PFS"/>
        <display value="Powder for Suspension"/>
        <definition
                    value="Powder that requires reconstitution into a liquid suspension before use."/>
      </concept>
      <concept>
        <code value="INJ"/>
        <display value="Injection"/>
        <definition
                    value="Sterile solution or suspension intended for parenteral administration."/>
      </concept>
      <concept>
        <code value="SOL"/>
        <display value="Solution"/>
        <definition
                    value="Liquid dosage form where drug is fully dissolved in a solvent."/>
      </concept>
      <concept>
        <code value="CRM"/>
        <display value="Cream"/>
        <definition
                    value="Semi-solid topical dosage form containing the drug in an emulsion base."/>
      </concept>
      <concept>
        <code value="LOT"/>
        <display value="Lotion"/>
        <definition
                    value="Low-viscosity liquid topical dosage form for external application."/>
      </concept>
    </CodeSystem>